Table 3.
Clinical features | Proportion | Penetrance (%) |
---|---|---|
Infections (bacterial/viral) | ||
P. jirovecii pneumonia | 3/3 | 100 |
Bacterial sepsis (Enterococcus etc.) | 1/3 | 33 |
Viral pneumonia (Rhinovirus etc.) | 1/3 | 33 |
LABORATORY TESTS | ||
Cell populations | ||
Normal total lymphocyte numbers | 3/3 | 100 |
↓ Treg | 3/3 | 100 |
↑ Naïve ↓ Memory B cells | 3/3 | 100 |
↑ Naïve ↓ Effector T cells | 2/2 | 100 |
Response | ||
↓ T cell proliferation (PHA, α-CD3/CD28) | 3/3 | 100 |
↓ NF-κB phosphorylation/IκBα degradation | 3/3 | 100 |
↓ IL-2 secretion | 3/3 | 100 |
Ig | ||
Panhypogammaglobulinemia | 3/3 | 100 |
Tabulation of findings that may be diagnostic clues for CARD11 deficiency. Included are the proportion of patients where the data is available as well as the percentage of patients with the specific phenotype. ↑, increased levels relative to normal range; ↓, decreased levels relative to normal range.